Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomideMax Jan, Benjamin L. Ebert, Andrea Schmidts et al.|Science Translational Medicine|2021Cited by 257
CARPOOL: A library-based platform to rapidly identify next generation chimeric antigen receptorsTaeyoon Kyung, Michael E. Birnbaum|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 4
Exploiting the Zinc Finger Degrome Targeted By Lenalidomide to Engineer Reversible Off-Switch Degradable Chimeric Antigen ReceptorsMax Jan, Benjamin L. Ebert, Ana P. Castaño et al.|Blood|2019Cited by 0